Anticancer Drugs Compared to No Anticancer Drugs in Patients with Advanced Hepatobiliary Cancer: A Mapping Review and Evidence Gap Map-Reference-Cited by-同舟云学术

Anticancer Drugs Compared to No Anticancer Drugs in Patients with Advanced Hepatobiliary Cancer: A Mapping Review and Evidence Gap Map

Published:2023-11 Issue: Volume:Volume 15 Page:1069-1085
ISSN:1179-1349
Container-title:Clinical Epidemiology
language:en
Short-container-title:CLEP

Author:

Requeijo Carolina^ORCID,Bracchiglione Javier,Meza Nicolás,Acosta-Dighero Roberto,Salazar Josefina,Santero Marilina^ORCID,Meade Adriana-G,Quintana María Jesús^ORCID,Rodríguez-Grijalva Gerardo,Selva Anna,Solà Ivan^ORCID,Urrútia Gerard^ORCID,Bonfill Cosp Xavier^ORCID

Publisher

Informa UK Limited

Subject

Epidemiology

Reference118 articles.

1. Surveillance Research Program, National Cancer Institute. SEER*Explorer: an interactive website for SEER cancer statistics [Internet]. In: Surveillance Research Program, National Cancer Institute [Internet]. [cited November 10, 2021]. Available from: https://seer.cancer.gov/explorer/. Accessed November 01, 2023.

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

3. Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline

4. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

5. Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy or targeted therapy versus best supportive care for advanced gastric cancer: a systematic review and meta-analysis of randomized trials;2024-07-15

2. Anti-cancer drugs versus supportive care for advanced biliary tract cancers: a systematic review;F1000Research;2024-06-07